Today (March 1, 2023), the opening ceremony of Taili Biotechnology (Suzhou) Co., Ltd. (hereinafter referred to as "Taili Biotechnology") was grandly held in the Suzhou Biomedical Industry Park.

The uncertain 2022 is far away, and we welcome 2023 with great anticipation. At the beginning of the new year, various tasks are about to begin. As an antibody production factory, EHS must consolidate the foundation of safety production and strive to take safety production management work to a higher level in the new year as the factory resumes production.

On November 10th, the 24th Shanghai International Biotechnology and Medicine Symposium (BIO-FORUM) series China Biotechnology and Medicine Innovation Forum and the 2022 China Biomedical Technology Innovation Value List Awards were grandly held in Shanghai.

On July 15, 2022, Shanghai Taichu Biotechnology Co., Ltd. (referred to as Taichu Biotechnology) and Yiming (Beijing) Cell Biotechnology Co., Ltd. (referred to as Yiming Cell) officially announced a strategic cooperation, with complementary advantages between the two parties

On May 18, 2022, in Shanghai, China, Weimu Biotechnology (Shanghai) Co., Ltd. (referred to as Weimu Biotechnology) and Shanghai Taijin Biotechnology Co., Ltd. (referred to as Taijin Biotechnology) announced the establishment of a strategic partnership, jointly committed to the development of bispecific antibody drugs related to fundus diseases.